Latest filing published 30 Sept 2026 for ADARx Pharmaceuticals, Inc., €918k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Since each purchase
- -32.3%Entry US$19.54 · Close 06 Nov 2026 US$13.23
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Erez Chimovits: trading record in brief
Erez Chimovits discloses dealings in 7 companies, chiefly BiomX Inc., ADARx Pharmaceuticals, Inc. and LogicBio Therapeutics, Inc. Between 23 October 2018 and 28 September 2026, the trades on record add up to 29 filings.
The open-market record is one-sided, with 17 purchases worth €57.9M and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 4 share grants. 2026 to date brings 3 purchases and no sales.
Half of the purchases are above €1.5M and half below. Clusters matter here: 15 out of 15 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.
Most recently, on 30 September 2026, the filings show an open-market purchase worth €918k in ADARx Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Erez Chimovits
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 61,516 shares@ US$17.00100.0% of flowCommon StockSEC:0000947871-26-000912:4Canonical exit: 27 Dec 2026 (T+90)
- 513,067 sharesCommon StockSEC:0000947871-26-000912:2
- 256,448 sharesCommon StockSEC:0000947871-26-000912:3
- 1,333,975 sharesCommon StockSEC:0000947871-26-000912:1
- 7,127,019 sharesCommon StockSEC:0000947871-26-000912:0
- 9,132,420 sharesCommon StockSEC:0000947871-26-000783:0
- 1,666,667 shares@ US$18.001.60% mcap85.9% of flowCommon StockSEC:0000947871-26-000783:1Canonical exit: 5 Nov 2026 (T+90)
- 273,333 shares@ US$18.000.26% mcap14.1% of flowCommon StockSEC:0000947871-26-000783:2Canonical exit: 5 Nov 2026 (T+90)
- 660,000 shares@ US$17.0080.0% of flowCommon StockSEC:0000947871-24-000807:3Canonical exit: 13 Jan 2025 (T+90)
- 165,000 shares@ US$17.0020.0% of flowCommon StockSEC:0000947871-24-000807:1Canonical exit: 13 Jan 2025 (T+90)
- 2,887,833 sharesCommon StockSEC:0000947871-24-000807:2
- 721,956 sharesCommon StockSEC:0000947871-24-000807:0
- 420,299 shares@ US$13.0080.2% of flowCommon StockSEC:0000947871-21-000242:0
- 104,050 shares@ US$13.0019.8% of flowCommon StockSEC:0000947871-21-000242:1
- 545,974 shares@ US$6.0036.9% of flowCommon StockSEC:0000947871-20-000776:0Canonical exit: 30 Dec 2020 (T+90)
- 639,212 shares@ US$6.0043.1% of flowCommon StockSEC:0000947871-20-000776:1Canonical exit: 30 Dec 2020 (T+90)
- 296,296 shares@ US$6.0020.0% of flowCommon StockSEC:0000947871-20-000776:2Canonical exit: 30 Dec 2020 (T+90)
- 292,607 sharesCommon StockSEC:0000947871-20-000740:1
- 902,885 sharesCommon StockSEC:0000947871-20-000740:0
- ▲
Same trade as the filing by OrbiMed Israel BioFund GP Limited Partnership, counted once
4,465 USD32SEC500 shares@ US$8.932.2% of flowCommon Stock, $0.001 par valueSEC:0000947871-19-000982:0Canonical exit: 17 Mar 2020 (T+90) - ▲
Same trade as the filing by OrbiMed Israel BioFund GP Limited Partnership, counted once
31,150 USD34SEC3,500 shares@ US$8.9015.6% of flowCommon Stock, $0.001 par valueSEC:0000947871-19-000982:1Canonical exit: 18 Mar 2020 (T+90) - ▲
Same trade as the filing by OrbiMed Israel BioFund GP Limited Partnership, counted once
29,750 USD33SEC3,400 shares@ US$8.7515.0% of flowCommon Stock, $0.001 par valueSEC:0000947871-19-000962:0Canonical exit: 9 Mar 2020 (T+90) - ▲
Same trade as the filing by OrbiMed Israel BioFund GP Limited Partnership, counted once
48,168 USD34SEC5,400 shares@ US$8.9224.2% of flowCommon Stock, $0.001 par valueSEC:0000947871-19-000962:1Canonical exit: 10 Mar 2020 (T+90) - ▲
Same trade as the filing by OrbiMed Israel BioFund GP Limited Partnership, counted once
27,166 USD27SEC3,400 shares@ US$7.9913.6% of flowCommon Stock, $0.001 par valueSEC:0000947871-19-000947:0Canonical exit: 4 Mar 2020 (T+90) - ▲
Same trade as the filing by OrbiMed Israel BioFund GP Limited Partnership, counted once
6,400 USD28SEC800 shares@ US$8.003.2% of flowCommon Stock, $0.001 par valueSEC:0000947871-19-000947:1Canonical exit: 5 Mar 2020 (T+90)
25 of 16 declarations